[A multricentric study of the antibacterial treatment of urogenital infections: report. Evaluation of 2 different therapeutic trends and of the effect of some factors related to the host and to the disease].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009268:Nalidixic Acid / Q000627:therapeutic use; D009582:Nitrofurantoin / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011472:Prostatitis / Q000188:drug therapy*; D011645:Puerperal Infection / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D013449:Sulfonamides; D009268:Nalidixic Acid; D009582:Nitrofurantoin
Una ricerca multicentrica sul trattamento antibatterico delle infezioni urogenitali: resoconto. Valutazione di due diversi indirizzi terapeutici e dell'influenza di alcuni fattori relativi all'ospite ed alla malattia.